InsidersTradesSigma
Browse the complete record of transactions filed by Marques Tiago, Chief Executive Officer. Director active across 1 companies, notably Pasithea Therapeutics Corp.. Aggregated, 3 disclosures have been published. The latest transaction was filed on 23 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Tiago Marques is the President and CEO of Pasithea Therapeutics Corp. He is responsible for the strategic direction of the company, overseeing its operations and ensuring the achievement of its growth objectives.